comparemela.com

Latest Breaking News On - Ys biopharma - Page 2 : comparemela.com

751,790 Shares in YS Biopharma Co , Ltd (NASDAQ:YS) Purchased by Hhlr Advisors LTD

Hhlr Advisors LTD. purchased a new position in YS Biopharma Co., Ltd. (NASDAQ:YS – Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 751,790 shares of the company’s stock, valued at approximately $1,203,000. Hhlr Advisors LTD. owned approximately 2.92% of YS Biopharma at the […]

Snow Lake Management LP Purchases Shares of 500,000 YS Biopharma Co , Ltd (NASDAQ:YSBPW)

Snow Lake Management LP acquired a new position in YS Biopharma Co., Ltd. (NASDAQ:YSBPW – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 500,000 shares of the company’s stock, valued at approximately $78,000. YS Biopharma comprises 0.0% of Snow Lake Management […]

Valliance Asset Management Ltd Acquires New Shares in YS Biopharma Co , Ltd (NASDAQ:YS)

Valliance Asset Management Ltd bought a new position in shares of YS Biopharma Co., Ltd. (NASDAQ:YS – Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 1,607,175 shares of the company’s stock, valued at approximately $2,571,000. YS Biopharma comprises approximately 4.6% of Valliance […]

YS Biopharma Co , Ltd (NASDAQ:YS) Short Interest Down 83 1% in June

YS Biopharma Co., Ltd. (NASDAQ:YS – Get Free Report) was the recipient of a large drop in short interest in June. As of June 30th, there was short interest totalling 277,800 shares, a drop of 83.1% from the June 15th total of 1,640,000 shares. Based on an average daily volume of 1,110,000 shares, the short-interest […]

Hallmark Financial Services (NASDAQ:HALL) Coverage Initiated by Analysts at StockNews com

YS Biopharma (NASDAQ:YS – Get Rating) and Oxus Acquisition (NASDAQ:OXUS – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk. Analyst Recommendations This is a summary of current ratings […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.